What Do the New Trials Tell Us About the Management of Hypertension?

Moderator:

Discussants:

  • Summary:

    Dr. Marvin Moser moderated the topic "What do the new trials tell us about the management of hypertension?" with Drs. Jan Basile, Professor of Medicine, Medical University of South Carolina, Charleston, SC, William Cushman, Professor of Preventive Medicine and Medicine, University of Tennessee College of Medicine, Memphis, TN and Norman Kaplan, Professor of Medicine, UT Southwestern Medical Center, Dallas, TX participating.

    Over the past three or four years, numerous hypertension treatment trials have been undertaken. Some of these were designed to determine (1) whether or not practicing physicians should be treating adolescent or very elderly hypertensive patients, (2) at what level should treatment be started, and (3) what are goal BP levels. Other trials have been designed to establish whether or not 130/80 should now be the goal for treatment instead of 140/90, especially in diabetic patients or patients with renal disease. Finally, there have been many comparative trials to determine whether there is a difference between the effectiveness of one drug combination compared to others. There is an ongoing debate about whether or not practicing physicians should treat an adolescent who has even transient systolic BP elevations of 145 or 150. There have also been debates for years regarding levels of BP to treat in the elderly. This roundtable addresses such questions as: (a) Do physicians ignore elevated BP at age 75, or at 80? (b) Do physicians ignore an 85-year-old person with systolic BP of 160 - 175? (c) Do physicians have any new data that help the practicing physicians resolve these issues? (Med Roundtable Cardiovasc Ed. 2010;1(1):54-60) ©2010 FoxP2 Media, LLC

  • Compounds:
    No compounds discussed.
    Trials:

    AASK, ABCD, ACCOMPLISH, ACCORD, ALLHAT, HDFP, HOT, HYVET, LIFE, MDRD, ONTARGET, SHEP, SYST-CHINA, SYST-EUR, UKPDS, VA

You are not authorized to access this content.

You are not authorized to access this content.
You are not authorized to access this content.
Please subscribe to use our print features or to download PDF files.